Navigation Links
Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
Date:2/5/2008

, single-administration, placebo-controlled study in

approximately 160 migraine patients with or without aura. Three doses

of AZ-104 (1.25, 2.5 and 5 mg) were evaluated against placebo in the

clinical trial. Using the IHS (International Headache Society) 4-point

rating scale, the primary efficacy endpoint is pain-relief response at

2 hours post-administration. Alexza expects preliminary findings to be

released by the end of Q1 2008. AZ-104 is being developed through

Symphony Allegro.

-- AZ-002 (Staccato alprazolam) is being developed for the acute treatment

of panic attacks associated with panic disorder. Alexza is conducting

a Phase 2a proof-of-concept clinical trial in panic disorder patients.

The primary aim of the in-clinic clinical trial is to assess the safety

and efficacy of a single dose of AZ-002 in treating a

pharmacologically-induced panic attack. Alexza has completed the

open-label, lead-in segment of the clinical trial, identifying the 1 mg

AZ-002 dose as an acceptable dose in terms of its safety and efficacy

profile, and has initiated the randomized, double blind,

placebo-controlled segment of the clinical trial. Alexza expects the

enrollment of this clinical trial to be completed by the end of Q2

2008. AZ-002 is being developed through Symphony Allegro.

-- AZ-003 (Staccato fentanyl) is being developed for the treatment of

breakthrough pain in cancer and non-cancer patients. In December 2007,

Alexza entered into a license and development agreement with Endo

Pharmaceuticals Holdings Inc. for development of AZ-003 and the

fentanyl class of molecules in North America. In the partnership,

Alexza has primary responsibility for the development of the Staccato

Electric Multiple Dose device and the exclusive right to manufactu
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015 Vermillion, ... solutions company focused on gynecologic disease, announced today ... results before the market open on Wednesday, March ... and webcast at 8:30am Eastern. Conference Call & ... at 8:30am Eastern/5:30am Pacific Domestic: , 800-753-9057International: , ...
(Date:3/5/2015)... 5, 2015  BioPhotas, Inc., an FDA registered medical ... photo-therapeutic technologies to treat skin, muscle and joint conditions, ... Fi Fund to provide BioPhotas, flagship product, the ... management solutions.  Commenting on the alliance, ... used the Celluma at the Warrior Hope and Care ...
(Date:3/5/2015)... HAMILTON, N.J. , March 5, 2015 /PRNewswire/ ... laboratory which specializes in high complexity, state-of-the-art, automated ... offering new Human Papillomavirus (HPV) testing which utilizes ... platforms. Each year, approximately 12,000 women ... the United States . Genital Human Papillomaviruses ...
Breaking Medicine Technology:Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
... 2012 Mylan Inc. (Nasdaq: MYL ) ... received final approval from the U.S. Food and Drug ... for Fluvastatin Capsules USP, 20 mg and 40 mg, ... Capsules. This product is indicated for the treatment of ...
... Maine, April 12, 2012 Expanding on the ... devices, Puritan Medical Products Co. LLC launches two ... use through its newly created division, Puritan Diagnostics ... Our universal transport media system has ...
Cached Medicine Technology:Mylan Launches First Generic Version of Lescol® Capsules 2Puritan Medical Products Company Launches New Diagnostic Collection and Transport Systems 2
(Date:3/6/2015)... Yisrayl Hawkins, Pastor and Overseer of The House ... publication explaining how micro-kingdoms keep the earth and everything ... “Microorganisms Do Much More Than You Think” is a ... and designed to keep all things functioning properly. He ... of these micro-kingdom, but does not realize their full ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 You ... company, created a unique ‘energy’ experiment to determine ... , After quick ‘5 -7 minute’ ... than 150+ countries reported their life improving - ... reported positive results. , According to research, respondents ...
(Date:3/6/2015)... 06, 2015 Los Angeles cosmetic dentist ... for Zoom whitening. Zoom is a special type of teeth ... Unlike other teeth whitening treatments, Zoom does its job in ... stains. For a limited time, Dr. Ghasri is offering Zoom ... usual price of $650 and allows patients to try out ...
(Date:3/6/2015)... 2015 Dr. Mark Sowell recently returned from ... AZ. Offering programs for advanced education in the field of ... , As a visiting faculty member of this prestigious ... each time he visits Spear Education to participate in a ... “we are training only the top 10% and those willing ...
(Date:3/6/2015)... March 06, 2015 Medical Products, Inc., ... an agreement with GE Healthcare to become an authorized ... United States. , MPI has 31 years in distribution ... Healthcare. , With this agreement, MPI will have the ... the healthcare industry. , MPI has always strived ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:Plano Dentist Teaches Dentists from Around the Globe at Spear Education 2
... Inc. (Pink Sheets: SETO) announced that it signed a Letter ... issue shares of its Common Stock to acquire 100% of ... Maryland corporation which provides hearing services and retails hearing aids ... (2) to sell all of SETO,s current businesses, i.e. ...
... Calif., March 5 New Leaf Creative Strategies, which ... its clients, is offering an introductory special media distribution ... is being held in Anaheim March 6 - 8.Visibility ... topics in the media right now. But when ...
... push is on to bring the U. S. health ... systems now used at many medical facilities with electronic ... To understand how best to realize the benefits these ... Polytechnic Institute (WPI) has launched a three-year study of ...
... MAYWOOD, Il. -- When Joyce Moss recently arrived at Loyola ... 42 minutes to perform an emergency balloon angioplasty. , The ... "There was no damage to the heart because of how ... good." , To further improve its emergency angioplasty times, Loyola ...
... 5 Fitch Ratings has affirmed its ... and its primary insurance subsidiaries.(Logo: http://www.newscom.com/cgi-bin/prnh/20081024/PROASSURANCELOGO )In ... their rating action , "...considers the solid financial ... as well as consistent profitability, financial and operating flexibility, ...
... Trubion Pharmaceuticals Inc. (Nasdaq: TRBN ) today ... the fourth quarter and year ended Dec. 31, 2008, ... The company,s earnings conference call will take place March ... Eastern Time. Both live events will be available for ...
Cached Medicine News:Health News:SETO Holdings, Inc. Signs Letter of Intent to Dispose of all its Existing Businesses and Acquire Advanced Hearing Centers, Inc.; New Management to be Installed. 2Health News:New Leaf Creative Strategies to Provide Real-Time Media Distribution Services at Natural Products Expo West 2Health News:Measuring the impact of electronic medical records 2Health News:Measuring the impact of electronic medical records 3Health News:Saving heart attack patients in the middle of the night 2Health News:Saving heart attack patients in the middle of the night 3Health News:Saving heart attack patients in the middle of the night 4Health News:Fitch Affirms ProAssurance's Rating and Stable Outlook 2Health News:Fitch Affirms ProAssurance's Rating and Stable Outlook 3Health News:Trubion Announces Dates for Fourth-Quarter and Year-Ended 2008 Earnings Conference Call 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: